Susan Simonyi

546 total citations
23 papers, 406 citations indexed

About

Susan Simonyi is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Susan Simonyi has authored 23 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Ophthalmology, 7 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Susan Simonyi's work include Glaucoma and retinal disorders (11 papers), Retinal Diseases and Treatments (10 papers) and Ocular Surface and Contact Lens (5 papers). Susan Simonyi is often cited by papers focused on Glaucoma and retinal disorders (11 papers), Retinal Diseases and Treatments (10 papers) and Ocular Surface and Contact Lens (5 papers). Susan Simonyi collaborates with scholars based in Canada, United States and South Korea. Susan Simonyi's co-authors include David Hollander, Michael E. Stern, Roger W. Beuerman, Louis Tong, Mel Krajden, Vincent G. Bain, Shoei‐Sheng Lee, Kevork Peltekian, Eric M. Yoshida and Morris Sherman and has published in prestigious journals such as Gut, American Journal of Ophthalmology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Susan Simonyi

22 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan Simonyi Canada 12 169 117 116 112 107 23 406
Hiten G. Sheth United Kingdom 10 154 0.9× 23 0.2× 36 0.3× 79 0.7× 51 0.5× 23 298
R. Rishi Gupta Canada 8 127 0.8× 64 0.5× 8 0.1× 65 0.6× 90 0.8× 39 271
Jeong Hun Bae South Korea 14 348 2.1× 3 0.0× 30 0.3× 61 0.5× 147 1.4× 43 500
Ming-Tsung Lee Taiwan 10 13 0.1× 10 0.1× 19 0.2× 78 0.7× 21 0.2× 25 255
Meike Dirks Germany 14 21 0.1× 134 1.1× 14 0.1× 177 1.6× 10 0.1× 27 366
Ching‐Yao Tsai Taiwan 11 241 1.4× 2 0.0× 40 0.3× 172 1.5× 197 1.8× 39 389
Crandall E. Peeler United States 9 92 0.5× 7 0.1× 14 0.1× 51 0.5× 28 0.3× 30 262
Dušica Pahor Slovenia 12 328 1.9× 2 0.0× 54 0.5× 35 0.3× 182 1.7× 71 413
Hana Guberina Germany 13 17 0.1× 48 0.4× 11 0.1× 70 0.6× 4 0.0× 20 273
Emrah Utku Kabataş Türkiye 11 112 0.7× 69 0.6× 62 0.6× 203 1.9× 32 476

Countries citing papers authored by Susan Simonyi

Since Specialization
Citations

This map shows the geographic impact of Susan Simonyi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Simonyi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Simonyi more than expected).

Fields of papers citing papers by Susan Simonyi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Simonyi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Simonyi. The network helps show where Susan Simonyi may publish in the future.

Co-authorship network of co-authors of Susan Simonyi

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Simonyi. A scholar is included among the top collaborators of Susan Simonyi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Simonyi. Susan Simonyi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vera, Vanessa, et al.. (2023). Gel Stent Versus Trabeculectomy: The Randomized, Multicenter, Gold-Standard Pathway Study (GPS) of Effectiveness and Safety at 12 Months. American Journal of Ophthalmology. 252. 306–325. 25 indexed citations
2.
Mitchell, Paul, Jennifer Arnold, Samantha Fraser‐Bell, et al.. (2023). Dexamethasone intravitreal implant in diabetic macular oedema refractory to anti-vascular endothelial growth factors: the AUSSIEDEX study. BMJ Open Ophthalmology. 8(1). e001224–e001224. 7 indexed citations
3.
Lin, Frank, et al.. (2023). CONTOUR Australia: Condition of Submental Fullness and Treatment Outcomes with Belkyra Registry. Plastic & Reconstructive Surgery Global Open. 11(7). e5123–e5123.
4.
Fraser‐Bell, Samantha, et al.. (2021). Dexamethasone intravitreal implant in treatment-naïve diabetic macular oedema: findings from the prospective, multicentre, AUSSIEDEX study. British Journal of Ophthalmology. 107(1). 72–78. 9 indexed citations
5.
Park, Sang Woo, et al.. (2021). Efficacy and safety of fixed-combination brimonidine tartrate/timolol maleate in primary open-angle glaucoma, including normal-tension glaucoma. Japanese Journal of Ophthalmology. 65(2). 295–305. 2 indexed citations
6.
Por, Yong Chen, et al.. (2018). Breast augmentation surgery using an inframammary fold incision in Southeast Asian women: Patient-reported outcomes. Archives of Plastic Surgery. 45(4). 367–374. 14 indexed citations
7.
Yoon, Young Hee, Jong Woo Kim, Joo Yong Lee, et al.. (2018). Dexamethasone Intravitreal Implant for Early Treatment and Retreatment of Macular Edema Related to Branch Retinal Vein Occlusion: The Multicenter COBALT Study. Ophthalmologica. 240(2). 81–89. 20 indexed citations
8.
Tong, Louis, Lei Zhou, Roger W. Beuerman, et al.. (2017). Effects of punctal occlusion on global tear proteins in patients with dry eye. The Ocular Surface. 15(4). 736–741. 20 indexed citations
9.
Tong, Louis, Roger W. Beuerman, Susan Simonyi, David Hollander, & Michael E. Stern. (2016). Effects of Punctal Occlusion on Clinical Signs and Symptoms and on Tear Cytokine Levels in Patients with Dry Eye. The Ocular Surface. 14(2). 233–241. 49 indexed citations
10.
11.
Kook, Michael S., Susan Simonyi, Yongho Sohn, Chan Yun Kim, & Ki Ho Park. (2015). Bimatoprost 0.01 % for previously treated patients with open-angle glaucoma or ocular hypertension in the Korean clinical setting. Japanese Journal of Ophthalmology. 59(5). 325–334. 7 indexed citations
12.
Park, Ki Ho, Susan Simonyi, Chan Yun Kim, Yongho Sohn, & Michael S. Kook. (2014). Bimatoprost 0.01% in treatment-naïve patients with open-angle glaucoma or ocular hypertension: an observational study in the Korean clinical setting. BMC Ophthalmology. 14(1). 160–160. 8 indexed citations
13.
14.
15.
16.
Jog, Mandar, et al.. (2011). Causes for Treatment Delays in Dystonia and Hemifacial Spasm: A Canadian Survey. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 38(5). 704–711. 29 indexed citations
17.
Yan, David B., et al.. (2009). Three-month, randomized, parallel-group comparison of brimonidine–timolol versus dorzolamide–timolol fixed-combination therapy. Current Medical Research and Opinion. 25(7). 1645–1653. 28 indexed citations
18.
Sherman, Morris, Eric M. Yoshida, Marc Deschênes, et al.. (2006). Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy. Gut. 55(11). 1631–1638. 65 indexed citations
19.
Lee, Shoei‐Sheng, Vincent G. Bain, Kevork Peltekian, et al.. (2006). Treating chronic hepatitis C with pegylated interferon alfa‐2a (40 KD) and ribavirin in clinical practice. Alimentary Pharmacology & Therapeutics. 23(3). 397–408. 55 indexed citations
20.
Marshall, Deborah A., et al.. (2005). Impact of administrative restrictions on antibiotic use and expenditure in Ontario: time series analysis. Journal of Health Services Research & Policy. 11(1). 13–20. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiten G. Sheth Breakdown of academic impact, for papers by R. Rishi Gupta Breakdown of academic impact, for papers by Jeong Hun Bae Breakdown of academic impact, for papers by Ming-Tsung Lee Breakdown of academic impact, for papers by Meike Dirks Breakdown of academic impact, for papers by Ching‐Yao Tsai Breakdown of academic impact, for papers by Crandall E. Peeler Breakdown of academic impact, for papers by Dušica Pahor Breakdown of academic impact, for papers by Hana Guberina Breakdown of academic impact, for papers by Emrah Utku Kabataş
Rankless by CCL
2026